Mario Rizzetto，都灵，意大利——HBV相关实验室及人物介绍系列
Mario Rizzetto，都灵，意大利——HBV相关实验室及人物介绍系列Mario Rizzetto，University of Torino, Italy，HDV发现者
Rizzetto, M. (2015). "Hepatitis D Virus: Introduction and Epidemiology." Cold Spring Harb Perspect Med 5(7): a021576.
Rizzetto, M. and A. Smedile (2015). "Pegylated interferon therapy of chronic hepatitis D: in need of revision." Hepatology 61(4): 1109-11.
Rosina, F. and M. E. Tosti, et al. (2014). "Pegylated interferon alpha plus ribavirin for the treatment of chronic hepatitisC: a multicentre independent study supported by the Italian Drug Agency." Dig Liver Dis 46(9): 826-32.
Ciancio, A. and M. Rizzetto (2014). "Chronic hepatitis D at a standstill: where do we go from here?" Nat Rev Gastroenterol Hepatol 11(1): 68-71.
Alberti, A. and M. Colombo, et al. (2014). "The dilemma for patients with chronic hepatitis C: treat now or warehouse?" Dig Liver Dis 46(1): 27-9.
Buti, M. and K. Agarwal, et al. (2014). "Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C." Gastroenterology 146(3): 744-753.e3.
Burdino, E. and T. Ruggiero, et al. (2014). "Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XLMurex HBsAg Quant: correlation with the ARCHITECT quantitative assays." J Clin Virol 60(4): 341-6.
Rizzetto, M. (2013). "Current management of delta hepatitis." Liver Int 33 Suppl 1: 195-7.
Rizzetto, M. and S. M. Alavian (2013). "Hepatitis delta: the rediscovery." Clin Liver Dis 17(3): 475-87.
Rizzetto, M. (2012). "Hepatitis D(delta)." Semin Liver Dis 32(3): 193-4.
Rizzetto, M. (2012). "Treatment of hepatitis B virus cirrhosis." Hepat Mon 12(5): 309-11.
Rizzetto, M. and A. Ciancio (2012). "Epidemiology of hepatitis D." Semin Liver Dis 32(3): 211-9.
Giaccone, L. and M. Festuccia, et al. (2010). "Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation." Biol Blood Marrow Transplant 16(6): 809-17.
Rizzetto, M. (2010). "Hepatitis D: clinical features and therapy." Dig Dis 28(1): 139-43.
Pellicano, R. and G. Puglisi, et al. (2008). "Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?" J Med Virol 80(4): 628-31.
Manzini, P. and M. Girotto, et al. (2007). "Italian blood donors with anti-HBc and occult hepatitis B virus infection." Haematologica 92(12): 1664-70.
Ciancio, A. and A. Smedile, et al. (2006). "Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are theyreally cured?" Am J Gastroenterol 101(8): 1811-6.
Ciancio, A. and P. Manzini, et al. (2005). "Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus." Ann Intern Med 142(11): 903-9.
Pellicano, R. and A. Craxi, et al. (2005). "Interferon beta-1a alone or in combination with ribavirin: a randomized trial tocompare efficacy and safety in chronic hepatitis C." World J Gastroenterol 11(29): 4484-9.
Pellicano, R. and F. Palmas, et al. (2002). "Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection." Eur J Gastroenterol Hepatol 14(12): 1377-82.
Rizzetto, M. (2002). "Efficacy of lamivudine in HBeAg-negative chronic hepatitis B." J Med Virol 66(4): 435-51.
Rizzetto, M. and A. R. Zanetti (2002). "Progress in the prevention and control of viral hepatitis type B: closing remarks." J Med Virol 67(3): 463-6.
Saracco, G. and A. Olivero, et al. (2002). "A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in thetreatment of patients with chronic hepatitis C relapsing after interferon monotherapy." Hepatology 36(4 Pt 1): 959-66.
Rizzetto, M. and M. G. Canese, et al. (1977). "Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers." Gut 18(12): 997-1003.
页:
[1]